Author:
McDonald Hannah G.,Kennedy Andrew,Solomon Angelica L.,Williams Chelsey M.,Reagan Anna M.,Cassim Emily,Harper Megan,Burke Erin,Armstrong Terra,Gosky Michael,Cavnar Michael,Pandalai Prakash K.,Barry-Hundeyin Mautin,Patel Reema,Nutalapati Snigdha,Moss Jessica,Hull Pamela C.,Kolesar Jill,Pickarski Justine C.,Kim Joseph
Publisher
Springer Science and Business Media LLC
Reference53 articles.
1. Raimondi S, Maisonneuve P, Lowenfels AB. Epidemiology of pancreatic cancer: an overview. Nat Rev Gastroenterol Hepatol. 2009;6(12):699–708. https://doi.org/10.1038/nrgastro.2009.177.
2. Buckles S. Clinic discovers gene mutations linked to pancreatic cancer, calls for expanded testing—Mayo Clinic news network. Available at: https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-discovers-gene-mutations-linked-to-pancreatic-cancer-calls-for-expanded-testing/. Accessed 2 Apr 2022.
3. Goggins M, Overbeek KA, Brand R, et al. Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium. Gut. 2020;69(1):7–17. https://doi.org/10.1136/gutjnl-2019-319352.
4. Sohal DPS, Kennedy EB, Cinar P, et al. Metastatic pancreatic cancer: ASCO guideline update. J Clin Oncol. 2020;38(27):3217–30. https://doi.org/10.1200/JCO.20.01364.
5. Aslanian HR, Lee JH, Canto MI. AGA clinical practice update on pancreas cancer screening in high-risk individuals: expert review. Gastroenterology. 2020;159(1):358–62. https://doi.org/10.1053/j.gastro.2020.03.088.